Disclosure: Was alerted to this one in 2023 and watched with interest, did not participate in the CR but was happy to purchase on market at $1.40 after CR.
Very happy to top up here today under $1.20 and will continue to soak up what’s available at this level or below.
Big 12-24 months coming up
Looking forward to next report.
Price has been up and down over last 5 years on nothing material IMO pretty much only speculation in hope of a US Rollout.
FDA approval granted & rollout now here, proven management and logistics, contracts signed, reimbursement by US Gov. Not much downside here IMO.
$90Million+ annual market in the US.
Rest of world $27Million (2024)
As the rollout continues over the next 12-24 months I see plenty of upside, fully funded for rollout with revenue increasing dramatically. Plenty of good news to come, unfortunately lung disease imaging is a very stable industry.
Love to hear regular updates & news from holders as I watch the rollout.
Add to My Watchlist
What is My Watchlist?
